Exhibitors
The HCM Summit gratefully acknowledges the following companies for their commitment to our 2026 event.
In accordance with ACCME Standards for Integrity and Independence, exhibitors have no influence over program content, speaker selection, or educational objectives.
EXTENDED OFFERINGS:
There are (10) optional 60-minute industry-sponsored sessions throughout HCM9 to complement our core scientific program.
All registrants are welcome to attend to hear focused industry perspectives on emerging therapies, technologies, and approaches relevant to contemporary HCM care.
Platinum
Diamond
Gold
Silver
Bronze
Sustainer
Disclosure Statement
The following company sponsors have active technology licenses, conduct research, support educational initiatives, or have clinical relationships with Beth Israel Lahey Medical Center, an entity of Beth Israel Lahey Health.
Alexion Pharmaceuticals
AstraZeneca Pharmaceuticals
Braveheart Bio
Bristol Myers Squibb
Chiesi, USA
Cytokinetics, Inc.
Edgewise Therapeutics, Inc.
Haya Therapeutics
Imbria Pharmaceuticals, Inc.
Lexicon Pharmaceuticals, Inc.
Sanofi